Literature DB >> 24321397

Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2.

Jane Yang1, Andrew M Goetze1, Gregory C Flynn2.   

Abstract

Antibody dimers, two self-associated monomers, have been detected on both recombinantly expressed and endogenous human IgG proteins. Nearly 10 years ago, Yoo et al. (2003) described low levels of IgG2 covalent dimer, in human serum, but did not quantify the levels. Here we quantify the total and covalent dimer levels of IgG2 and IgG1 in human blood, and study the origin of covalent dimer formation. Low levels (<1%) of total IgG1 and IgG2 dimers were measured in freshly prepared human plasma. Both IgG1 and IgG2 covalent dimers were also found in plasma. Whereas IgG1 covalent dimer levels were significantly reduced by steps intended to eliminate artifacts during sample preparation, IgG2 covalent dimer levels remain stable in such conditions. About 0.4% of IgG2 in plasma was in a covalent dimer form, yet very little (<0.03%) of IgG1 covalent dimer could be considered naturally occurring. IgG2 dimer also formed in vitro under conditions designed to mimic those in blood, suggesting that formation occurs in vivo during circulation. Thus, small amounts of covalent IgG2 dimer do appear to form naturally.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody structure; DTT; Disulfide formation; Disulfide isoforms; EDTA; GFB; HC; HL; L-1-tosylamido-2-phenylethyl chloromethyl ketone; LC; LC/MS; N-ethylmaleimide; NEM; Oxidation–reduction; Protein degradation; SDS-PAGE; SEC; TFA; TPCK; V(o); dithiothreitol; ethylene diamine tetraacetic acid; glufibrinopeptide B; half molecule; heavy chain; light chain; liquid chromatography/mass spectrometry; size-exclusion chromatography; sodium dodecyl sulfate-polyacrylamide gel electrophoresis; trifluoroacetic acid; void volume

Mesh:

Substances:

Year:  2013        PMID: 24321397     DOI: 10.1016/j.molimm.2013.11.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Authors:  Austin W Boesch; James H Kappel; Alison E Mahan; Thach H Chu; Andrew R Crowley; Nana Y Osei-Owusu; Galit Alter; Margaret E Ackerman
Journal:  Biotechnol Bioeng       Date:  2018-02-01       Impact factor: 4.530

2.  The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands.

Authors:  Lucy E Rayner; Gar Kay Hui; Jayesh Gor; Richard K Heenan; Paul A Dalby; Stephen J Perkins
Journal:  J Biol Chem       Date:  2015-02-06       Impact factor: 5.157

3.  Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.

Authors:  Friederike Plath; Philippe Ringler; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Melissa A Graewert; Dmitri Svergun; Gerald Gellermann; Christof Finkler; Jan O Stracke; Atanas Koulov; Volker Schnaible
Journal:  MAbs       Date:  2016-03-31       Impact factor: 5.857

Review 4.  Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.

Authors:  Austin W Boesch; Galit Alter; Margaret E Ackerman
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

5.  Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.

Authors:  M Christian Tjiam; James P A Taylor; Mazmah A Morshidi; Lucy Sariputra; Sally Burrows; Jeffrey N Martin; Steven G Deeks; Dino B A Tan; Silvia Lee; Sonia Fernandez; Martyn A French
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

6.  Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens.

Authors:  Nicholas J Harmer; Richard Chahwan
Journal:  Virulence       Date:  2016-05-25       Impact factor: 5.882

7.  Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.

Authors:  Laila N Abudulai; Sonia Fernandez; Karli Corscadden; Sally A Burrows; Michael Hunter; M Christian Tjiam; Lea-Ann S Kirkham; Jeffrey J Post; Martyn A French
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

Review 8.  Engineering Antibodies for the Treatment of Infectious Diseases.

Authors:  Gaowei Fan; Jinming Li
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.